|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 3/27/2009 |
| Termination Date | 3/27/2012 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, breast cancer affects one in eight women. Risks factors include: age, genes, being overweight, use of hormone replacement therapy, use of birth control pills, alcohol consumption and other personal factors. This activity is supported in part by educational grants from Merck and Astellas.
NCCN Clinical Practice Guidelines in Oncology Breast Cancer (PDF: 748K) |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Charles Shapiro, MD |
| Objectives | Upon completion of this educational activity, the participant should be able to: 1.) Review the indications for prescribing bisphosphonates for bone loss in women with breast cancer.
2.) Review the anit-tumor effects of Bisphophonates in the adjuvant setting. |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
